š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study was conducted to evaluate the lot-to-lot consistency of three lo...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1999-04
Trial ID
NCT00696917
Treatments Being Tested
This study compares the immunogenicity and safety of the novel adjuvanted H...
Status
Completed
Location
Multiple Locations
Start Date
1999-04
Trial ID
NCT00697749
Treatments Being Tested
This study evaluates the safety and immunogenicity of the candidate HBV-MPL...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1997-03
Trial ID
NCT00697216
Treatments Being Tested
The purpose of the present trial is to assess the safety, reactogenicity an...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1995-06
Trial ID
NCT00697840
This trial is designed to evaluate the immunogenicity, reactogenicity and s...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1992-02
Trial ID
NCT00699231
Treatments Being Tested
The purpose of this study is to evaluate the safety, immunogenicity and rea...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1992-09
Trial ID
NCT00697229
Treatments Being Tested
The purpose of this study is to compare the immunogenicity and reactogenici...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1997-05
Trial ID
NCT00697931
Treatments Being Tested
The purpose of the present study is to evaluate the immunogenicity and safe...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00697866
Treatments Being Tested
This study is undertaken to assess the immune response and safety profile o...
Status
Completed
Location
GSK Clinical Trial Call Center
Start Date
1998-11
Trial ID
NCT00697853
Treatments Being Tested
The purpose of the study is to compare the safety, reactogenicity and immun...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1995-01
Trial ID
NCT00698087
Treatments Being Tested